Press Releases

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for emergency use a booster dose of the Moderna COVID-19 vaccine (mRNA-1273) at the 50 µg dose level for people...

Johnson & Johnson announced the U.S. FDA has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot...

Crystec Ltd. and Biosidus S.A. are delighted to announce their collaboration focused on enhancing the delivery and performance of biotherapeutics. The overarching aim of the non-exclusive partnership is to apply Crystec’s proprietary mSAS® (modified supercritical antisolvent) supercritical fluid particle...

Possessing the world’s strongest cargo flight network, Turkish Cargo contributes its strength to Turkey’s medical exports. Flag carrier air cargo brand has been carrying Turkey’s medicine and medical products to over 50 countries in five continents for over 25...

InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The release of two new products for oncology that have no equals on...

Modus Therapeutics Holding AB , a company developing innovative treatments for patients with high unmet medical needs, announces that Symbiosis Pharmaceutical Services Ltd (“Symbiosis”), a specialist contract manufacturing organization (CMO), has started manufacturing sevuparin drug product securing the supply...

BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide,  announced that BRUKINSA® (zanubrutinib) has been approved in Australia for the treatment of adult patients with mantle...